| Mr James Edward Beecham, MD | |
|
3186 S Maryland Parkway, Las Vegas, NV 89109 | |
| (702) 731-8000 | |
| Not Available |
| Full Name | Mr James Edward Beecham |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 3186 S Maryland Parkway, Las Vegas, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780645648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | 5627 (Nevada) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 5627 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr James Edward Beecham, MD Po Box 98604, Las Vegas, NV 89193-8604 Ph: (702) 732-3441 | Mr James Edward Beecham, MD 3186 S Maryland Parkway, Las Vegas, NV 89109 Ph: (702) 731-8000 |
News Archive
Low levels of HDL cholesterol, the so-called 'good' cholesterol, are the most common lipid disorder in countries in Latin America and the Caribbean, a new meta-analysis published in eLife shows.
About 50 million people in the EU suffer from neurological diseases such as epilepsy, migraines, multiple sclerosis, Parkinson's disease, strokes and dementia.
Accera, Inc., a biotech company specializing in cognitive health, announced today that it has identified the genetic profile of Alzheimer's disease (AD) patients who have a high probability of responding to Axona (AC-1202), a prescription medical food product available at pharmacies nationwide.
BioMarin Pharmaceutical Inc. today announced an update on the Phase I/II trial for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0 mg/kg) have been evaluated, and BioMarin plans to announce top-line results for the full 36-week study after completion of dosing at 2.0 mg/kg in the second quarter of 2010.
› Verified 3 days ago
Mrs. June Durkee Sigman, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 7455 W Washington Ave Ste 301, Las Vegas, NV 89128 Phone: 877-562-5227 Fax: 702-732-2310 | |
Dr. Bert G. Dougherty, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3059 S Maryland Pkwy, 100, Las Vegas, NV 89109 Phone: 702-732-3441 Fax: 702-732-2310 | |
Dr. David Patrick Marmaduke, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3059 S Maryland Pkwy Ste 100, Las Vegas, NV 89109 Phone: 702-732-3441 Fax: 702-732-2310 | |
Narciss Mobini, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4230 Burnham Ave, Las Vegas, NV 89119 Phone: 702-733-7866 Fax: 702-792-1319 | |
Mr. Jonathan Howard Hughes, MD PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3059 S Maryland Pkwy Ste 100, Las Vegas, NV 89109 Phone: 702-732-3441 Fax: 702-732-2310 | |
Peter Aylward Scully, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 4230 Burnham Avenue, Las Vegas, NV 89119 Phone: 702-733-7866 Fax: 702-792-1319 | |
Jonathan Stuart Strauss, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4230 Burnham Ave, Las Vegas, NV 89119 Phone: 702-733-7866 Fax: 702-792-1319 |